Medeologix Inc. announced that it will issue not more than 12,600,000 common shares at an issue price of TWD 25 per share for proceeds of not more than TWD 315,000,000 on January 18, 2024. The transaction will include participation from returning investor Medeon Biodesign, Inc. The transaction was approved by the board of directors of the company.